ACTAVIA LIFE SCIENCES, INC. Repayments of Notes Payable
ACTAVIA LIFE SCIENCES, INC. reported Repayments of Notes Payable of $8.51 thousand for the 3-month period ending 2023-12-31, per its 10-Q filed 2024-02-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfNotesPayable · last filed 2024-02-16
- ACTAVIA LIFE SCIENCES, INC. repayments of notes payable for the quarter ending 2023-12-31 was $8.51K, a 58.33% decline year-over-year.
- ACTAVIA LIFE SCIENCES, INC. repayments of notes payable for the quarter ending 2023-09-30 was $14.14K, a 53.83% decline year-over-year.
- ACTAVIA LIFE SCIENCES, INC. repayments of notes payable for the quarter ending 2023-06-30 was $9.74K.
- ACTAVIA LIFE SCIENCES, INC. repayments of notes payable for the quarter ending 2023-03-31 was $21.57K.
- ACTAVIA LIFE SCIENCES, INC. repayments of notes payable for fiscal 2023 was $65.86K, a 4.30% decline from fiscal 2022.
- ACTAVIA LIFE SCIENCES, INC. repayments of notes payable for fiscal 2022 was $68.82K.
| Period end | Repayments of Notes Payable 3 month | Repayments of Notes Payable 6 month | Repayments of Notes Payable 9 month | Repayments of Notes Payable 12 month |
|---|---|---|---|---|
| 2023-12-31 | $8.51K 10-Q · filed 2024-02-16 | $22.65K derived: sum of 2 quarters · filed 2024-02-16 | $32.38K derived: sum of 3 quarters · filed 2024-02-16 | $53.95K derived: sum of 4 quarters · filed 2024-02-16 |
| 2023-09-30 | $14.14K derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-05 | $23.88K derived: sum of 2 quarters · filed 2024-01-05 | $45.44K derived: sum of 3 quarters · filed 2024-01-05 | $65.86K 10-K · filed 2024-01-05 |
| 2023-06-30 | $9.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $31.30K derived: sum of 2 quarters · filed 2023-08-14 | $51.72K 10-Q · filed 2023-08-14 | $82.35K derived: sum of 4 quarters · filed 2024-02-16 |
| 2023-03-31 | $21.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-15 | $41.98K 10-Q · filed 2023-05-15 | $72.61K derived: sum of 3 quarters · filed 2024-02-16 | |
| 2022-12-31 | $20.42K 10-Q · filed 2024-02-16 | $51.05K derived: sum of 2 quarters · filed 2024-02-16 | ||
| 2022-09-30 | $30.63K derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-05 | $68.82K 10-K · filed 2024-01-05 | ||
| 2022-06-30 | $38.19K 10-Q · filed 2023-08-14 |